Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Perez K, Gadgil M, Dizon DS. Sexual ramifications of medical illness. Clin Obstet Gynecol. 2009;52(4):691-701.
2. American Association of Diabetes Educators. The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 4th ed. Chicago, IL: American Association of Diabetes Educators; 2017.
3. American Diabetes Association. Standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Suppl 1):S1-S244.
4. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Available at https://www.cdc.gov/diabetes/data/statistics-report/index.html. Last accessed March 12, 2024.
5. Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag. 2017;20(1):6-12.
6. Barker LE, Kirtland KA, Gregg E, Geiss I, Thompson T. Geographic distribution of diagnosed diabetes in the United States: a diabetes belt. Am J Prev Med. 2011;40(4):434-439.
7. Westerfield J, Holcomb S, Jensen S (eds). Current Trends in Diabetes Management: A Guide for the Healthcare Professional. 7th ed. Nashville, TN: Healthways; 2008.
8. American Diabetes Association. Statistics about Diabetes. Available at https://www.diabetes.org/resources/statistics/statistics-about-diabetes. Last accessed March 12, 2024.
9. U.S. Department of Health and Human Services Office of Minority Health. Diabetes and Hispanic Americans. Available athttps://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=63. Last accessed March 14, 2024.
10. U.S. Department of Health and Human Services Office of Minority Health. Diabetes and American Indians/Alaska Natives. Available at https://www.minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=33. Last accessed March 14, 2024.
11. Acton KJ, Burrows NR, Moore K, Querec L, Geiss LS, Engelgau MM. Trends in diabetes prevalence among American Indian and Alaska Native children, adolescents, and young adults. Am J Public Health. 2002;92(9):1485-1490.
12. Temneanu OR, Trandafir LM, Purcarea MR. Type 2 diabetes mellitus in children and adolescents: a relatively new clinical problem within pediatric practice. J Med Life. 2016;9(3):235-239.
13. Colberg S, Friesz M. Diabetes Free Kids: A Take-Charge Plan for Preventing and Treating Type 2 Diabetes in Children. New York, NY: Avery; 2005.
14. Goldstein BJ, Müller-Wieland D (eds). Type 2 Diabetes: Principles and Practice. 2nd ed. New York, NY: Informa Healthcare; 2008.
15. Childs BP, Cypress M, Spollett G (eds). Complete Nurse's Guide to Diabetes Management. 4th ed. Alexandria, VA: American Diabetes Association; 2017.
16. National Institute of Diabetes and Digestive and Kidney Diseases. Risk Factors for Type 2 Diabetes. Available at https://www.niddk.nih.gov/health-information/diabetes/overview/risk-factors-type-2-diabetes. Last accessed March 14, 2024.
17. Edelman SV, Henry RR. Diagnosis and Management of Type 2 Diabetes. 11th ed. New York, NY: Professional Communications; 2011.
18. Lindau ST, Gavrilova N. Sex, health and years of sexually active life gained due to good health: evidence from two United States population based cross sectional surveys of ageing. BMJ. 2010;340(810):1-11.
19. Feldhaus-Dahir M. Treatment options for female sexual arousal disorder: part II. Urol Nurs. 2010;3(4):247-251.
21. Moktar A, Rodway GW, Huether SE. Structure and function of the reproductive systems. In: Huether SE, McCance KL (eds). Understanding Pathophysiology. 6th ed. St. Louis, MO: Mosby; 2016: 779-801.
22. Fode M, Sønksen J, McPhee SJ, Ohl DA. Disorders of the male reproductive tract. In: Hammer GD, McPhee SJ(eds). Pathophysiology of Disease: An Introduction to Clinical Medicine. 7th ed. New York, NY: McGraw Hill; 2014: 651-676.
23. West CM, Pelter MM. Ischemia. In: Carrieri-Kohlman V, Lindsey AM, West CM (eds). Pathophysiological Phenomena in Nursing: Human Response to Illness. 3rd ed. St. Louis, MO: Saunders; 2003: 413-438.
24. Fisher M, Shaw KM. Diabetes and the heart. In: Shaw KM, Cummings MH (eds). Diabetes: Chronic Complications. 3rd ed. West Sussex: Wiley; 2012: 165-189.
25. Cummings MH. Diabetes and sexual health. In: Shaw KM, Cummings MH (eds). Diabetes: Chronic Complications. 3rd ed. West Sussex: Wiley; 2012: 141-164.
26. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res. 1998;10(Suppl 2):S84-S90.
27. Berman JR. Physiology of female sexual function and dysfunction. Int J Impot Res. 2005;17:S44-S51.
28. Alatas E, Yagci B, Oztekin O, Sabir N. Effect of hormone replacement therapy on clitoral artery blood flow in healthy postmenopausal women. J Sex Med. 2008;5(10):2367-2373.
29. Böhm M, Baumhäkel M, Teo K, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ongoing telmisartarn alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease. Circulation. 2010;121(12):1439-1446.
30. Vinik AI, Vinik EJ. Diabetic neuropathies. In: Mensing C, Cornell S, Halstenson C (eds). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
31. Venes D (ed). Taber's Cyclopedic Medical Dictionary. 22nd ed. Philadelphia, PA: FA Davis Company; 2013.
32. Roszler J. Sex and Diabetes and Much, Much, More! Paper presented at: American Association of Diabetes Educators Annual Conference. 2010; San Antonio, TX.
34. Fabbri A, Greco E, Aversa A. Erectile dysfunction. In: Leslie RD, Pozzilli P (eds). Diabetic Complications. London: Martin Dunitz; 2003: 55-72.
35. Brunton SA, Sadovsky R. Late-onset male hypogonadism and testosterone replacement therapy in primary care. J Fam Pract. 2010;59(7 Suppl):1-8.
38. Frank JE, Mistretta P, Will J. Diagnosis and treatment of female sexual dysfunction. Am Fam Physician. 2008;77(5):635-642.
39. Esposito K, Maiorino MI, Bellastella G, Giugliano F, Romano M, Giugliano D. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res. 2010;22(3):179-184.
40. Phillips NA. Female sexual dysfunction: evaluation and treatment. Am Fam Physician. 2000;62(1):127-136.
41. Bø K. Pelvic floor muscle training in treatment of female stress urinary incontinence, pelvic organ prolapse and sexual dysfunction. World J Urol. 2012;30(4):437-443.
42. Ruggiero L, Wagner J, De Groot M. Understanding the individual: emotional and psychological challenges. In: Mensing C, Cornell S, Halstenson C (eds). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
43. Gao L, Yang L, Qian S, Li T, Han P, Yuan J. Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction. Int J Gynaecol Obstet. 2016;133(2):139-145.
44. Chivers ML, Rosen RC. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms? J Sex Med. 2010;7(2 Pt 2):858-872.
45. Springhouse (ed). Nursing 2010 Drug Handbook. Philadelphia, PA: Lippincott, Williams & Wilkins; 2009.
46. LexiComp Online. Available at https://online.lexi.com. Last accessed March 14, 2024.
47. U.S. Food and Drug Administration. FDA Approves Stendra for Erectile Dysfunction. Available at https://wayback.archive-it.org/7993/20170112023943/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302140.htm. Last accessed March 14, 2024.
48. Sanford M. Avanafil: a review of its use in patients with erectile dysfunction. Drugs Aging. 2013;30(10):853-862.
49. Wang H, Yuan J, Hu X, Tao K, Liu J, Hu D. The effectiveness and safety of avanafil for erectile dysfunction: a systematic review and meta-analysis. Curr Med Res Opin. 2014;30(8):1565-1571.
50. Kennedy S. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder. J Sex Med. 2010;7(10):3449-3459.
51. Hitt E. FDA Advisory Committee Votes Against Flibanserin for Hypoactive Sexual Disorder. Available at https://www.medscape.com/viewarticle/723896. Last accessed March 14, 2024.
52. Sprout Pharmaceuticals. Sprout Pharmaceuticals Appeals FDA Decision on New Drug Application for Flibanserin to Treat Hypoactive Sexual Desire Disorder in Premenopausal Women. Available at https://www.prnewswire.com/news-releases/sprout-pharmaceuticals-appeals-fda-decision-on-new-drug-application-for-flibanserin-to-treat-hypoactive-sexual-desire-disorder-in-premenopausal-women-235380991.html. Last accessed March 14, 2024.
53. U.S. Food and Drug Administration. FDA Approves First Treatment for Sexual Desire Disorder. Available at https://wayback.archive-it.org/7993/20170112023753/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm458734.htm. Last accessed March 14, 2024.
54. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRIUS). J Sex Med. 2011;8(11):3204-3213.
55. Davis SR, Worsley R, Miller KK, Parish SJ, Santoro N. Androgens and female sexual function and dysfunction: findings from the Fourth International Consultation of Sexual Medicine. J Sex Med. 2016;13(2):168-178.
56. Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008;359(19):2005-2017.
57. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33.
58. Women's Health Initiative. Available at https://www.nhlbi.nih.gov/science/womens-health-initiative-whi. Last accessed March 14, 2024.
59. Elder JA, Braver Y. Female Sexual Dysfunction. Available at https://teachmemedicine.org/cleveland-clinic-female-sexual-dysfunction/. Last accessed March 14, 2024.
60. Enzlin P, Mathieu C, Van den Bruel A, Vanderschueren D, Demyttenaere K. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care. 2003;26(2):409-414.
61. American Diabetes Association. Sexual Implications of Emotional Health. Available at https://diabetes.org/health-wellness/sexual-health/sexual-implications-emotional-health. Last accessed March 14, 2024.
62. Solowiejczyk J. Diabetes and depression: some thoughts to think about. Diabetes Spectrum. 2010;23(1):11-15.
63. Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol. 2019;56(6):631-650.
64. Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res. 2010;22(3):204-209.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.